Dishman Carbogen Amcis Company Description

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide.

The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments.

It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables.

The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Dishman Carbogen Amcis Limited

Country	India
Founded	1983
Industry	Biotechnology
Sector	Healthcare
Employees	1,132
CEO	Arpit Vyas

Contact Details

Address: Dishman Corporate House Ahmedabad, Gujarat 380058 India
Phone	91 27 1742 0102
Website	imdcal.com

Stock Details

Ticker Symbol	DCAL
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE385W01011
SIC Code	2833

Key Executives

Name	Position
Dr. Stephan Fritschi Ph.D.	Chief Executive Officer of CARBOGEN AMCIS
Jayesh A. Shah	Chief Executive Officer of Production
Dr. Himani S. Dhotre	Chief Executive Officer of Projects and Operations
Arpit Janmejay Vyas	Global MD and Director
Deohooti Janmejay Vyas	Whole Time Director
Harshil R. Dalal	Global Chief Financial Officer
Paolo Armanino	Chief Operating Officer of Indian Operations
Shrima Gaurangbhai Dave	Compliance Officer and Company Secretary
Dharmesh Desai	GM of Secretarial and Legal
. Gavin	Head of ESH